PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
Condition: Lynch Syndrome Intervention: Drug: PD-1 Antibody Sponsors: Sun Yat-sen University; Second Affiliated Hospital, School of Medicine, Zhejiang University; Fujian Cancer Hospital; Guangdong Provincial People's Hospital; Guangdong Provincial Hospital of Traditional Chinese Medicine; The Third Affiliated Hospital of Kunming Medical Colle ge. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | China Health | HNPCC | Hospitals | Lynch Syndrome | Polyps | Research